A break in mitochondrial endosymbiosis as a basis for inflammatory diseases

Michael P. Murphy; Luke O'neill

doi:10.1038/s41586-023-06866-z

Related publications

Article2006

Targeting signal transduction as a strategy to treat inflammatory diseases

Luke O'neill

Nature Reviews Drug Discovery

Article2015

A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases

Rebecca C. Coll, Avril A. B. Robertson, Jae Jin Chae, Sarah Higgins, Raúl Muñoz-Planillo, Marco Inserra, Irina Vetter, Lara S. Dungan, Brian G. Monks, Andrea Stutz, Daniel E. Croker, Mark S. Butler, Moritz Haneklaus, Caroline E. Sutton, Gabriel Núñez, Eicke Latz, Daniel L. Kastner, Kingston H. G. Mills, Seth L. Masters, Kate Schroder, Matthew A. Cooper, Luke O'neill

Nature Medicine

Article2004

Genetic resources as basis for new resistant apple cultivars

Manfred M. Fischer, C. Fischer

Journal of Fruit and Ornamental Plant Research

Article2007

The potential of targeting Toll-like receptor 2 in autoimmune and inflammatory diseases

Eva M. Pålsson‐McDermott, Luke O'neill

Irish Journal of Medical Science (1971 -)

Article2012

A role for the NLRP3 inflammasome in metabolic diseases—did Warburg miss inflammation?

Haitao Wen, Jenny P.‐Y. Ting, Luke O'neill

Nature Immunology